GLP-1 Medications and Energy Metabolism in Weight Loss
Researchers investigating why GLP-1 medications work differently for everyone have found a link between energy metabolism and treatment outcomes.

Medications like Ozempic and Wegovy have become essential tools for managing obesity in the medical profession, but they don't work equally well for everyone.
Research has shown that when used weekly for 68 weeks alongside lifestyle interventions, GLP-1 medications can reduce body weight by an average of 15 percent. The success of these medications is largely due to their ability to regulate blood sugar and appetite through semaglutide, a key component.
However, the way semaglutide works is not identical for every individual, leading researchers to investigate why some people respond better than others. A multidisciplinary team at the University of Alberta is working to improve obesity care by understanding the underlying factors that influence treatment outcomes.
The team's investigation suggests that energy metabolism may play a crucial role in determining how well individuals respond to semaglutide. This complex process involves multiple variables, and researchers are working to identify key factors that contribute to successful weight loss.
Studies have shown that GLP-1 medications can improve overall health and quality of life by reducing blood markers such as sugar and cholesterol levels. They also lead to increased strength and better overall well-being, making them a valuable tool in obesity management.
When trying to lose weight, it's not just about reducing calorie intake or increasing physical activity. Energy metabolism plays a crucial role in weight loss, and understanding this process can provide valuable insights into why some people struggle to shed pounds.
Energy metabolism is the balance between the calories we consume and those our bodies burn. This occurs constantly, even when we're doing simple tasks like breathing, thinking, or digesting food. As we engage in physical activities, such as going to the gym, our energy expenditure increases, helping us to lose weight.
However, sometimes the body adapts to weight loss by reducing its energy needs. This is known as metabolic adaptation, where the body conserves energy by burning fewer calories than expected. This automatic "energy-saving mode" can make it more challenging to continue losing weight over time, leading to a weight-loss plateau in some individuals.
Changes in body composition also influence energy metabolism. Both fat and muscle mass require energy for basic bodily functions, even when we're at rest. As our bodies lose these tissues during weight loss, our energy expenditure naturally decreases. This reduction can make it harder to maintain weight loss over the long term.
Understanding how weight-loss medications affect energy metabolism could be a crucial step in developing more effective strategies for maintaining weight loss. Researchers are still exploring whether these medications influence the body's natural response to weight loss, and studying this process could lead to better outcomes for individuals struggling with obesity.
Researchers are still investigating the intricacies of how semaglutide affects energy utilization in the body. This is a crucial aspect of understanding why individuals respond differently to weight-loss medications like Ozempic and Wegovy.
A recent review of studies on GLP-1 therapies revealed that findings regarding resting energy use were neutral or inconclusive, highlighting the need for further exploration. At present, there is limited information available on how semaglutide impacts energy use, making it an open question waiting to be addressed by researchers.
To study energy utilization in a controlled environment, scientists at the University of Alberta utilize a whole-room indirect calorimeter, which measures each component of energy expenditure with precision. This specialized facility can isolate changes in calorie burning during rest, after eating, and during exercise, providing valuable insights into how semaglutide affects energy use.
Researchers are currently recruiting participants for a six-month study to investigate the effects of semaglutide on weight loss and body composition. Participants will have blood sugar regulation issues, such as insulin resistance or diabetes, and will be followed closely to examine changes in their weight and energy utilization using advanced approaches.
By understanding how semaglutide influences energy use and body composition, researchers can better anticipate potential non-responders and offer alternative treatments sooner in the treatment process. This knowledge could also contribute to more personalized approaches to obesity and Type 2 diabetes management, ultimately leading to improved health outcomes for individuals struggling with these conditions.
Research suggests that individuals taking semaglutide or considering treatment should also make some adjustments to their lifestyle.
This involves adopting healthier habits such as regular physical activity and a balanced diet, which can complement medication and enhance its effectiveness.
Facts based on reporting originally published by ScienceDaily Health.
You may republish this story, in full or in part, if you credit Noti Group and link to it (licence CC BY 4.0). Photos are not included.











